Title  | Date  | Price |
|---|
Thrombopoiesis-Stimulating Agents (TPO)
Competitor Analysis
| Nov 2009 |
£135 |
Global Cardiac Rhythm Management (CRM) Market Report: 2009 Edition
| Aug 2009 |
£485 |
Global Cardiovascular Drugs Market 2009-2024
| Jun 2009 |
£1,499 |
Japan Markets for Peripheral Vascular Devices
| May 2009 |
£4,505 |
InvestFrost Chemicals - U.S. Heart Health Ingredients Market
| Apr 2009 |
£3,605 |
U.S. Market for Interventional Cardiology 2009
| Apr 2009 |
£4,205 |
Overview of General Hospital Consumables and Cardiovascular Products Market in Sri Lanka
| Mar 2009 |
£3,605 |
InvestFrost Chemicals - European Heart Health Ingredients Market
| Mar 2009 |
£3,605 |
Cardiovascular Business Digest - U.S. Heart Valve Market
| Feb 2009 |
£3,605 |
China Hypertension Drug Market Report
The Chinese Hospital Cancer Drug Utilization
| Feb 2009 |
£4,950 |
Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets
| Feb 2009 |
£7,955 |
Stem Cells for Cardiovascular Disease 2009 Market Report
| Jan 2009 |
£2,000 |
The Cardiovascular Market Outlook to 2013
Competitive Landscape, Global Market Analysis and Pipeline Analysis
| Jan 2009 |
£2,305 |
European Market for Cadiac Rhythm Management, Electrophysiology, and Ablation Devices 2009 (15 Countries)
| Jan 2009 |
£6,910 |
Cardiovascular Market Digest - U.S. CRM Market
| Dec 2008 |
£3,605 |
Austrian Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
Beneluxian Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
U.S. Cardiovascular Business Digest - Drug Eluting Stent Market
| Sep 2008 |
£3,605 |
U.K. Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
U.S. Market for Vascular Access Devices & Accessories 2008
| Sep 2008 |
£4,505 |
European Markets for Vascular Access Devices 2008 (15 Countries)
| Sep 2008 |
£6,910 |
Scandinavian Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
German Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
French Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
Swiss Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
Italian Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
Portuguese Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
Spanish Market for Vascular Access Devices 2008
| Sep 2008 |
£2,700 |
Australian Cardiology PACS Markets
| Aug 2008 |
£3,605 |
U.S. Market for Cardiac Rhythm Management Devices 2008
| Aug 2008 |
£3,305 |
Antithrombotics
Competitor Analysis
| Jul 2008 |
£445 |
Antihypertensives
Competitor Analysis
| Jun 2008 |
£270 |
Cardiovascular Peptides
Competitor Analysis
| Jun 2008 |
£180 |
Adenosine Receptor Agonists & Antagonists
Competitor Analysis
| May 2008 |
£110 |
Advances in Cardiovascular Drug Therapies (Technical Insights)
| Mar 2008 |
£3,910 |
Latin American Cardiovascular Drugs Markets
| Jan 2008 |
£4,765 |
Nuclear Cardiology Markets
| Dec 2007 |
£1,235 |
US Market for Interventional Cardiology 2008
| Nov 2007 |
£4,505 |
Japanese Market for Peripheral Vascular 2008
| Nov 2007 |
£4,505 |
Japanese Markets for Interventional Cardiology 2007
| Jun 2007 |
£4,505 |
previous
